Performance characteristics of HIV RNA screening with long-acting injectable cabotegravir (CAB-LA) pre-exposure prophylaxis (PrEP) in the multicenter global HIV Prevention Trials Network 083 (HPTN 083) Study

Authors

• R. Landovitz, University of California, Los Angeles David Geffen School of Medicine, Los Angeles,CA
• F. Gao, Fred Hutchinson Cancer Center, Seattle, WA
• J.M. Fogel, Johns Hopkins University School of Medicine, Baltimore, MD
• B. Hanscom, Fred Hutchinson Cancer Center, Seattle, WA
• M. Clement, LSU Health Sciences Center - New OrleansFollow
• H.V. Tran, University of North Carolina at Chapel Hill, Chapel Hill, NCFollow
• A.H. Gaur, St Jude Children's Research Hospital, Memphis, TN
• C.J. Fichtenbaum, University of Cincinnati, Cincinnati, OH
• E. Piwowar-Manning, Johns Hopkins University School of Medicine, Baltimore, MD
• A. Moser, Johns Hopkins University School of Medicine, Baltimore, MD
• M.A. Marzinke, Johns Hopkins University School of Medicine, Baltimore, MD
• J. Mellors, University of Pittsburgh, Pittsburgh, PA
• E.K. Halvas, University of Pittsburgh, Pittsburgh, PA
• M. McCauley, FHI 360, Durham, NC
• K. Gomez-Feliciano, FHI 360, Durham, NC
• A. Jennings, FHI 360, Durham, NC
• L. Soto-Torres, National Institute of Allergy and Infectious Disease, Rockville, MD
• S. Zwerski, National Institute of Allergy and Infectious Disease, Rockville, MD
• J.F. Rooney, Gilead Sciences, Foster City, CA
• C. Acuipil, ViiV Healthcare, Durham, NC
• A.R. Rinehart, ViiV Healthcare, Research Triangle Park, NC
• M.S. Cohen, University of North Carolina at Chapel Hill, Chapel Hill, NC
• B. Grinsztejn, Instituto de Pesquisa Clinica Evandro Chagas-Fiocruz, Rio de Janeiro, Brazil
• S.H. Eshleman, Johns Hopkins University School of Medicine, Baltimore, MD

Document Type

Conference Proceeding

Publication Date

7-1-2024

Publication Title

Journal of the International AIDS Society

Abstract

5th HIV Research for Prevention Conference, HIVR4P 2024, October 6 -10, 2024, Peru, Lima

First Page

97

Volume

27

Issue

4, Supplement

Comments

Abstract Number: OAE0406LB

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Recommended Citation

Landovitz, R.; Gao, F.; Fogel, J.M.; Hanscom, B.; Clement, M.; Tran, H.V.; Gaur, A.H.; Fichtenbaum, C.J.; Piwowar-Manning, E.; Moser, A.; Marzinke, M.A.; Mellors, J.; Halvas, E.K.; McCauley, M.; Gomez-Feliciano, K.; Jennings, A.; Soto-Torres, L.; Zwerski, S.; Rooney, J.F.; Acuipil, C.; Rinehart, A.R.; Cohen, M.S.; Grinsztejn, B.; and Eshleman, S.H., "Performance characteristics of HIV RNA screening with long-acting injectable cabotegravir (CAB-LA) pre-exposure prophylaxis (PrEP) in the multicenter global HIV Prevention Trials Network 083 (HPTN 083) Study" (2024). School of Medicine Faculty Publications. 4545.
https://digitalscholar.lsuhsc.edu/som_facpubs/4545
10.1002/jia2.26279